Table 1.

Characteristics of patients in this study mSNVsā€”missense SNVs

Patient #Age at blood donationDiagnosisSmoking historyStage at resectionStage at blood donationTime between resection and blood donationPrior treatmentsTreatment at blood donationmSNVsMutations screened
51173Adeno carcinomaYesIV lymph nodeIV30 monthsCarboplatin/pemetrexedPemetrexed50546
149062Adeno carcinomaYesIB lung tumorIII13 monthsNoneCarboplatin, paclitaxel, radiation13046
134764Squamous cell CarcinomaYesIIB lung tumorNo evidence of disease10 monthsCarboplatin/PaclitaxelNone6557
113969Adeno carcinomaYesStage IV lung tumorIV27 monthsCarboplatin/pemetrexedNivolumab38848
123868Adeno carcinomaNoIIIA lung tumorIV23 monthsCisplatin/pemetrexed, afatinib, pembrolizumab, docetaxel/ramicirumabRamicirumab34+ Her2 ITD20+ Her2 ITD